Raymond James Company: The Viking Therapeutics (VKTX.US) rating was raised from superior to the market to a strong buy rating, and the target price was adjusted from $115.00 to $116.00.
雷蒙德詹姆斯公司：上调Viking Therapeutics(VKTX.US)评级，由优于大市调整至强烈买入评级, 目标价由115.00美元调整至116.00美元。
Raymond James Company: The Viking Therapeutics (VKTX.US) rating was raised from superior to the market to a strong buy rating, and the target price was adjusted from $115.00 to $116.00.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.